Table 2. Percentage of patients who achieved target HbA1c^a, target fasting plasma glucose^b, and change in body weight from baseline to each visit by prescription group.

Variable	Group A	Group B	Group C	P value
Number	0504	2,316	81
Proportion of patients, % (HbA1c <7.0%)
At 3 months	17.1	10.2	30	0.001
At 6 months	40.9	39.6	35.8	0.666
Proportion of patients, % (HbA1c <6.5%)
At 3 months	7.1	3.6	5.0	0.535
At 6 months	17.3	8.7	18.5	<0.001
Proportion of patients, % (FPG <130 mg/dL)
At 3 months	25.3	29.7	46.2	0.004
At 6 months	30.5	56.1	53.9	<0.001
∆ Body weight, kg
At 6 months	0.1±2.6	0.3±1.9	0.6±2.5	0.606
∆ BMI, kg/m2
At 6 months	0.08±1.18	0.11±0.79	0.39±1.18	0.113

Values are presented as mean±standard deviation. P values were calculated using chi-square test and analysis of variance.

HbA1c, glycosylated hemoglobin; FPG, fasting plasma glucose; BMI, body mass index.

^a<7.0% or <6.5%, ^b<130 mg/dL.